Clinical Trials Browser

Phase 2 × Gliosarcoma × poly ICLC × Clear all

NCT00052715 2018-07-18

Poly-ICLC

Phase 2 Terminated

31 enrolled 8 charts

Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma